Centers for Medicare and Medicaid Innovation; Drug Pricing and Medicare Parts B and D; Medicaid Funding; Medicare Advantage; Medicare Hospital/Provider Reimbursement Policy; Medicare Regulatory Reform; Medicare Shared Savings Program; 340B Drug Pricing Program
2026 · 3rd Quarter (July 1 - Sep 30)
ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.)
Filed by ADVOCATE HEALTH (FKA ADVOCATE AURORA HEALTH, INC.).
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 14, 2026
- Income
- Not reported
- Expenses
- $250,000.00
- Filing UUID
- 2cc6eba5-1b21-41e2-b076-1f01d6933caa
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
340B Drug Pricing Program; Alternative Payment Models; Anti-Kickback Statute Reform; Artificial Intelligence; Behavioral Health; COVID-19; Drug Pricing; Emergency Provider Relief Fund; FY 2026 Appropriations; FY 2027 Appropriations; Graduate Medical Education; Health Care Innovation; Health Sector Cybersecurity; Health Workforce; Hospital at Home; Mental Health; Post-Acute and Home Health Care Payments; Stark Law Reform/Modernization; Surprise Billing/Price Transparency; Telehealth/Digital Health; Value-Based Initiatives, Food is Medicine
Medical school funding and resident slots; clinical lab regulations, grant funding for research
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.